Editing

Following a breakthrough trial where gene-editing technology CRISPR completed its first systematic delivery as medicine to a human body, Intellia Therapeutics CEO John Leonard said he hopes the gene therapy could be made available to…

Gene-editing technology CRISPR reached a major milestone this past weekend, completing its first systemic delivery as a medicine to a human body.CRISPR, or clustered regularly interspaced short palindromic repeats, effectively cuts genomes…

The New York Times announced on Wednesday a return to its leadership team in the newsroom with the appointment of its Subway editor, Clifford J. Levy.Levy, 53, a two-time Pulitzer Prize winner, has been running the subway counter since…